Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CSL | Sydney | Healthcare | Pharmaceuticals | A$136.47B | 33.2x | 1.66 | A$281.83 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.3% Upside | Upgrade to Pro+ | |
Ebos | Sydney | Healthcare | Pharmaceuticals | A$6.73B | 24.3x | 3.92 | A$34.15 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.9% Upside | Upgrade to Pro+ | |
Sigma Pharma | Sydney | Healthcare | Pharmaceuticals | A$4.53B | -1,430x | 12.85 | A$2.88 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -29.3% Downside | Upgrade to Pro+ | |
Neuren Pharma | Sydney | Healthcare | Pharmaceuticals | A$1.64B | 14.1x | 0.12 | A$12.83 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Clinuvel Pharmaceuticals | Sydney | Healthcare | Pharmaceuticals | A$653.80M | 18.3x | 1.02 | A$13.09 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Botanix Pharma | Sydney | Healthcare | Pharmaceuticals | A$599.76M | -36.7x | 2.87 | A$0.33 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mayne Pharma | Sydney | Healthcare | Pharmaceuticals | A$420.35M | -2.4x | 0.01 | A$5.18 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.5% Upside | Upgrade to Pro+ | |
AFT Pharmaceuticals | Sydney | Healthcare | Pharmaceuticals | A$271.60M | 27.8x | -0.82 | A$2.59 | -5.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biome Australia | Sydney | Healthcare | Pharmaceuticals | A$122.71M | -85.9x | -1.54 | A$0.57 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vita Life Sciences | Sydney | Healthcare | Pharmaceuticals | A$110.79M | 0.45 | A$1.97 | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Recce | Sydney | Healthcare | Pharmaceuticals | A$108.98M | -4.7x | 0.18 | A$0.47 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Syntara | Sydney | Healthcare | Pharmaceuticals | A$87.88M | -4x | -0.66 | A$0.06 | -4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Neurizon Therapeutics | Sydney | Healthcare | Pharmaceuticals | A$85.16M | -8.3x | 1.46 | A$0.17 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Radiopharm Theranostics | Sydney | Healthcare | Pharmaceuticals | A$63.02M | -0.2x | 0.14 | A$0.03 | -5.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Inoviq | Sydney | Healthcare | Pharmaceuticals | A$59.67M | -7.5x | -0.29 | A$0.54 | 7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vitura Health | Sydney | Healthcare | Pharmaceuticals | A$58.17M | 14.1x | -0.22 | A$0.10 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medical Developments | Sydney | Healthcare | Pharmaceuticals | A$48.44M | -0.9x | 0 | A$0.43 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Starpharma Holdings | Sydney | Healthcare | Pharmaceuticals | A$45.91M | -5.3x | -0.12 | A$0.11 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Next Science | Sydney | Healthcare | Pharmaceuticals | A$39.44M | -2.7x | -0.07 | A$0.14 | 5.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Little Green Pharma | Sydney | Healthcare | Pharmaceuticals | A$36.34M | -4x | 0.02 | A$0.14 | 12.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41.7% Upside | Upgrade to Pro+ | |
Oncosil Medical Ltd | Sydney | Healthcare | Pharmaceuticals | A$35.87M | -1.4x | -0.07 | A$0.008 | 7.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nyrada | Sydney | Healthcare | Pharmaceuticals | A$22.01M | -6.1x | -0.18 | A$0.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Immuron Ltd | Sydney | Healthcare | Pharmaceuticals | A$19.71M | -2.9x | 0.03 | A$0.09 | 8.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Calmer Co International | Sydney | Healthcare | Pharmaceuticals | A$17.61M | -2.7x | -0.05 | A$0.008 | 14.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Althea | Sydney | Healthcare | Pharmaceuticals | A$17.27M | -0.4x | 0 | A$0.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Acrux | Sydney | Healthcare | Pharmaceuticals | A$12.50M | -2.2x | 0 | A$0.04 | -4.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Argent BioPharma | Sydney | Healthcare | Pharmaceuticals | A$11.94M | -0.5x | -0.01 | A$0.22 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Firebrick Pharma | Sydney | Healthcare | Pharmaceuticals | A$10.93M | -10.1x | -0.11 | A$0.05 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Anatara Lifesciences Ltd | Sydney | Healthcare | Pharmaceuticals | A$10.03M | -5.2x | -0.14 | A$0.05 | 4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TrivarX | Sydney | Healthcare | Pharmaceuticals | A$7.31M | -4x | -0.06 | A$0.02 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |